2014年第43卷19期
共12篇1. Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease. 6701-15页
作者:David J,Hayne; SinChun,Lim; Paul S,Donnelly
2. Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. 6692-700页
作者:Samuel A,Kotler; Patrick,Walsh; Jeffrey R,Brender; Ayyalusamy,Ramamoorthy
3. P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases. 6716-26页
作者:Andrew A,Pieper; Steven L,McKnight; Joseph M,Ready
4. Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain. 6814-38页
作者:Paramita,Mukherjee; Maris A,Cinelli; Soosung,Kang; Richard B,Silverman
5. PET/SPECT imaging agents for neurodegenerative diseases. 6683-91页
作者:Lin,Zhu; Karl,Ploessl; Hank F,Kung
6. Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs. 6750-64页
作者:Hyunbum,Jang; Fernando Teran,Arce; Srinivasan,Ramachandran; Bruce L,Kagan; Ratnesh,Lal; Ruth,Nussinov
7. Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. 6859-69页
作者:Rebecca A,Kohnz; Daniel K,Nomura
8. Molecular medicine and neurodegenerative diseases. 6668-71页
作者:Christopher J,Chang; Benjamin F,Cravatt; Douglas S,Johnson; Mi Hee,Lim
9. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond. 6839-58页
作者:Scott A,Yuzwa; David J,Vocadlo
10. BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. 6765-813页
作者:Arun K,Ghosh; Heather L,Osswald